Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,722 | 12,471 | 4,506 | 10,486 | 0 |
| Depreciation Amortization | 29,186 | 21,789 | 14,513 | 7,401 | 0 |
| Income taxes - deferred | 644 | N/A | N/A | -150 | N/A |
| Accounts receivable | -3,941 | 3,361 | 16,631 | 3,354 | N/A |
| Other Working Capital | 15,308 | 9,858 | 11,022 | 6,141 | 0 |
| Other Operating Activity | 15,880 | -1,127 | -21,161 | -9,541 | 0 |
| Operating Cash Flow | $71,799 | $46,352 | $25,511 | $17,691 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,093 | -2,331 | -1,050 | -299 | 0 |
| Purchase Of Investment | -4,093 | -16,630 | N/A | N/A | N/A |
| Other Investing Activity | -12,314 | 172 | 20 | -152 | 0 |
| Investing Cash Flow | $-20,500 | $-18,789 | $-1,030 | $-451 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,000 | 49,000 | 49,000 | 49,000 | N/A |
| Debt Repayment | -59,000 | -54,000 | -2,500 | 0 | N/A |
| Dividend Paid | -19,886 | -14,691 | -9,075 | N/A | 0 |
| Other Financing Activity | 317 | 0 | 0 | -218 | 0 |
| Financing Cash Flow | $-29,569 | $-19,691 | $37,425 | $48,782 | $0 |
| Exchange Rate Effect | 589 | 86 | -186 | -260 | 0 |
| Beginning Cash Position | 64,520 | 64,520 | 64,520 | 64,520 | 0 |
| End Cash Position | 86,839 | 72,478 | 126,240 | 130,282 | 0 |
| Net Cash Flow | $22,319 | $7,958 | $61,720 | $65,762 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 71,799 | 46,352 | 25,511 | 17,691 | 0 |
| Capital Expenditure | -16,579 | -2,331 | -1,050 | -299 | N/A |
| Free Cash Flow | 55,220 | 44,021 | 24,461 | 17,392 | 0 |